InspireMD, Inc. (NSPR)
NASDAQ: NSPR · IEX Real-Time Price · USD
2.010
+0.050 (2.55%)
At close: May 2, 2024, 3:57 PM
1.880
-0.130 (-6.47%)
After-hours: May 2, 2024, 7:47 PM EDT

InspireMD Revenue

In the year 2023, InspireMD had annual revenue of $6.21M with 20.00% growth. Revenue in the quarter ending December 31, 2023 was $1.76M with 71.64% year-over-year growth.

Revenue (ttm)
$6.21M
Revenue Growth
+20.00%
P/S Ratio
7.35
Revenue / Employee
$95,462
Employees
65
Market Cap
47.04M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.21M1.03M20.00%
Dec 31, 20225.17M676.00K15.04%
Dec 31, 20214.50M2.01M80.89%
Dec 31, 20202.49M-1.24M-33.22%
Dec 31, 20193.72M120.00K3.33%
Dec 31, 20183.60M840.00K30.42%
Dec 31, 20172.76M867.00K45.78%
Dec 31, 20161.89M-416.00K-18.01%
Dec 31, 20152.31M-508.00K-18.03%
Dec 31, 20142.82M-2.06M-42.17%
Jun 30, 20134.87M-476.00K-8.90%
Jun 30, 20125.35M-655.00K-10.91%
Dec 31, 20116.00M1.06M21.32%
Dec 31, 20104.95M1.54M45.09%
Dec 31, 20093.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nortech Systems 139.33M
Rockwell Medical 83.61M
IRIDEX 51.87M
Cytosorbents 36.35M
Daxor 34.67M
Renalytix 2.41M
Matinas BioPharma Holdings 1.10M
Revenue Rankings